Michael S. Niederman, MD
CME Objective: To review current evidence for prevention, diagnosis, treatment, and practice improvement of community-acquired pneumonia.
Funding Source: American College of Physicians.
Disclosures: Dr. Niederman, ACP Contributing Author, reports personal fees from Pfizer, personal fees from Thermo Fisher Scientific, grants and personal fees from Merck/Bayer, and personal fees from Cempra outside the submitted work. Disclosures can also be viewd at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0907
In the Clinic does not necessarily represent official ACP clinical policy. For ACP clinical guidelines, please go to https://www.acponline.org/clinical_information/guidelines/.
With the assistance of additional physician writers, the editors of Annals of Internal Medicine develop In the Clinic using MKSAP and other resources of the American College of Physicians.
This issue provides a clinical overview of community-acquired pneumonia, focusing on prevention, diagnosis, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.
Niederman MS. Community-Acquired Pneumonia. Ann Intern Med. ;163:ITC1. doi: 10.7326/AITC201510060
Download citation file:
© 2018
Published: Ann Intern Med. 2015;163(7):ITC1.
DOI: 10.7326/AITC201510060
Hospital Medicine, Infectious Disease, Prevention/Screening, Pulmonary/Critical Care, Vaccines/Immunization.
Results provided by: